Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.
Lipids such as ceramides (Cer) and phosphatidylcholines (PC) have been found altered in the plasma of Alzheimer's disease (AD) patients in a number of discovery studies. For this reason, the levels of 6 ceramides and 3 PCs, with different fatty acid length and saturation levels, were measured i...
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
IOS Press
2016
|
| _version_ | 1826306312032485376 |
|---|---|
| author | Kim, M Nevado-Holgado, A Whiley, L Snowden, S Soininen, H Kloszewska, I Mecocci, P Tsolaki, M Vellas, B Thambisetty, M Dobson, R Powell, J Lupton, M Simmons, A Velayudhan, L Lovestone, S Proitsi, P Legido-Quigley, C |
| author_facet | Kim, M Nevado-Holgado, A Whiley, L Snowden, S Soininen, H Kloszewska, I Mecocci, P Tsolaki, M Vellas, B Thambisetty, M Dobson, R Powell, J Lupton, M Simmons, A Velayudhan, L Lovestone, S Proitsi, P Legido-Quigley, C |
| author_sort | Kim, M |
| collection | OXFORD |
| description | Lipids such as ceramides (Cer) and phosphatidylcholines (PC) have been found altered in the plasma of Alzheimer's disease (AD) patients in a number of discovery studies. For this reason, the levels of 6 ceramides and 3 PCs, with different fatty acid length and saturation levels, were measured in the plasma from 412 participants (AD n = 205, Control n = 207) using mass spectrometry coupled with ultra-performance liquid chromatography. After this, associations with AD status, brain atrophy, and age-related effects were studied. In the plasma of AD participants, cross-sectional analysis revealed elevated levels of three ceramides (Cer16:0 p < 0.01, Cer18:0 p < 0.01, Cer24:1 p < 0.05). In addition, two PCs in AD plasma (PC36:5 p < 0.05, PC38:6 p < 0.05) were found to be depleted compared to the control group, with PC36:5 also associating with hippocampal atrophy (p < 0.01). Age-specific analysis further revealed that levels of Cer16:0, Cer18:0, and Cer20:0 were associated with hippocampal atrophy only in younger participants (age < 75, p < 0.05), while all 3 PCs did so in the older participants (age > 75, p < 0.05). PC36:5 was associated with AD status in the younger group (p < 0.01), while PC38:6 and 40:6 did so in the older group (p < 0.05). In this study, elevated ceramides and depleted PCs were found in the plasma from 205 AD volunteers. Our findings also suggest that dysregulation in PC and ceramide metabolism could be occurring in different stages of AD progression. |
| first_indexed | 2024-03-07T06:46:02Z |
| format | Journal article |
| id | oxford-uuid:fae1b5c7-9002-40da-b83b-e2db75307309 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:46:02Z |
| publishDate | 2016 |
| publisher | IOS Press |
| record_format | dspace |
| spelling | oxford-uuid:fae1b5c7-9002-40da-b83b-e2db753073092022-03-27T13:09:45ZAssociation between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:fae1b5c7-9002-40da-b83b-e2db75307309EnglishSymplectic Elements at OxfordIOS Press2016Kim, MNevado-Holgado, AWhiley, LSnowden, SSoininen, HKloszewska, IMecocci, PTsolaki, MVellas, BThambisetty, MDobson, RPowell, JLupton, MSimmons, AVelayudhan, LLovestone, SProitsi, PLegido-Quigley, CLipids such as ceramides (Cer) and phosphatidylcholines (PC) have been found altered in the plasma of Alzheimer's disease (AD) patients in a number of discovery studies. For this reason, the levels of 6 ceramides and 3 PCs, with different fatty acid length and saturation levels, were measured in the plasma from 412 participants (AD n = 205, Control n = 207) using mass spectrometry coupled with ultra-performance liquid chromatography. After this, associations with AD status, brain atrophy, and age-related effects were studied. In the plasma of AD participants, cross-sectional analysis revealed elevated levels of three ceramides (Cer16:0 p < 0.01, Cer18:0 p < 0.01, Cer24:1 p < 0.05). In addition, two PCs in AD plasma (PC36:5 p < 0.05, PC38:6 p < 0.05) were found to be depleted compared to the control group, with PC36:5 also associating with hippocampal atrophy (p < 0.01). Age-specific analysis further revealed that levels of Cer16:0, Cer18:0, and Cer20:0 were associated with hippocampal atrophy only in younger participants (age < 75, p < 0.05), while all 3 PCs did so in the older participants (age > 75, p < 0.05). PC36:5 was associated with AD status in the younger group (p < 0.01), while PC38:6 and 40:6 did so in the older group (p < 0.05). In this study, elevated ceramides and depleted PCs were found in the plasma from 205 AD volunteers. Our findings also suggest that dysregulation in PC and ceramide metabolism could be occurring in different stages of AD progression. |
| spellingShingle | Kim, M Nevado-Holgado, A Whiley, L Snowden, S Soininen, H Kloszewska, I Mecocci, P Tsolaki, M Vellas, B Thambisetty, M Dobson, R Powell, J Lupton, M Simmons, A Velayudhan, L Lovestone, S Proitsi, P Legido-Quigley, C Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. |
| title | Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. |
| title_full | Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. |
| title_fullStr | Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. |
| title_full_unstemmed | Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. |
| title_short | Association between Plasma Ceramides and Phosphatidylcholines and Hippocampal Brain Volume in Late Onset Alzheimer's Disease. |
| title_sort | association between plasma ceramides and phosphatidylcholines and hippocampal brain volume in late onset alzheimer s disease |
| work_keys_str_mv | AT kimm associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT nevadoholgadoa associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT whileyl associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT snowdens associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT soininenh associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT kloszewskai associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT mecoccip associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT tsolakim associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT vellasb associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT thambisettym associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT dobsonr associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT powellj associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT luptonm associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT simmonsa associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT velayudhanl associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT lovestones associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT proitsip associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease AT legidoquigleyc associationbetweenplasmaceramidesandphosphatidylcholinesandhippocampalbrainvolumeinlateonsetalzheimersdisease |